Page last updated: 2024-09-05

sorafenib and piperazine

sorafenib has been researched along with piperazine in 1 studies

Compound Research Comparison

Studies (sorafenib)	Trials (sorafenib)	Recent Studies (post-2010) (sorafenib)	Studies (piperazine)	Trials (piperazine)	Recent Studies (post-2010) (piperazine)
6,520	730	5,251	1,139	8	521

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abd El Razik, HA; Abu-Serie, MM; El-Miligy, MM	1

Other Studies

1 other study(ies) available for sorafenib and piperazine

Article	Year
Synthesis of piperazine-based thiazolidinones as VEGFR2 tyrosine kinase inhibitors inducing apoptosis. Future medicinal chemistry, 2017, Volume: 9, Issue:15 Topics: Apoptosis; Binding Sites; Caspases; Cell Line, Tumor; Hep G2 Cells; Humans; Molecular Docking Simulation; Niacinamide; Phenylurea Compounds; Piperazine; Piperazines; Protein Kinase Inhibitors; Protein Structure, Tertiary; Sorafenib; Staurosporine; Thiazolidines; Vascular Endothelial Growth Factor Receptor-2	2017

Article

Year

Synthesis of piperazine-based thiazolidinones as VEGFR2 tyrosine kinase inhibitors inducing apoptosis.

Future medicinal chemistry, 2017, Volume: 9, Issue:15

Topics: Apoptosis; Binding Sites; Caspases; Cell Line, Tumor; Hep G2 Cells; Humans; Molecular Docking Simulation; Niacinamide; Phenylurea Compounds; Piperazine; Piperazines; Protein Kinase Inhibitors; Protein Structure, Tertiary; Sorafenib; Staurosporine; Thiazolidines; Vascular Endothelial Growth Factor Receptor-2

2017